Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed 
Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab
New objective response in colon cancer triggers trial expansionLEXINGTON, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN),...
Zogenix and Leading Experts to Present New Rare Epilepsy Data at AES 2020
New long-term safety, efficacy, and durability data for FINTEPLA® (fenfluramine) oral solution in Dravet syndromeFull results from Phase 3 study...
Galectin Therapeutics to Webcast Corporate Update on December 3, 2020 after Annual Meeting of Stockholders
NORCROSS, Ga., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin...
Sensus Healthcare Announces Study Showing Single Low Dose of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision
Prospective study published in Journal of the American Academy of Dermatology BOCA RATON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sensus...
Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
HST-001 Demonstrated Separation from Placebo at Week 18 Primary Efficacy Endpoint Assessment HST-001 Found to be Safe and Well Tolerated...
AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer
VALENCIA, Calif, and MELBOURNE, Australia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine...
BridgeBio Pharma and Affiliate QED Therapeutics Announce FDA Acceptance of New Drug Application for Infigratinib for the Treatment of Cholangiocarcinoma
• Application accepted under Priority Review designation• Application accepted into Real Time Oncology Review (RTOR) pilot program• This is BridgeBio’s second NDA...
Jushi Holdings Inc. Announces Listing of 10% Senior Secured Notes Due January 15, 2023 on the Canadian Securities Exchange
BOCA RATON, Fla., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
VitalHub Subsidiary Transforming Systems Secured Contract with Bedfordshire, Luton & Milton Keynes ICS
TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that...
Athira Pharma Announces Initiation of Patient Dosing for ACT-AD Clinical Trial of ATH-1017, Small Molecule HGF/MET Activator, for Treatment of Mild-to-Moderate Alzheimer’s Disease
SEATTLE, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent
Extended collaboration with leading global generics company Sandoz for optimal antibiotic drug positioning by predictive antibiotic susceptibility testing Presenting study...
Cytokinetics Announces Additional Results From GALACTIC-HF to be Presented at the 17th Global Cardiovascular Clinical Trialists Forum
Data from Supplemental Analyses to be Shared at Clinical Trials Think Tank MeetingSOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE...
Aptose to Hold Corporate Update Sunday, December 6th
Corporate event to provide clinical update for CG-806 in AML and B-cell Cancers Poster Presentations for CG-806 and APTO-253 are...
Plus Therapeutics Expands ReSPECT™ Clinical Trial to MD Anderson Cancer Center
AUSTIN, Texas., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing novel,...
Study underway in BC to estimate how many young people have been infected with SARS-CoV-2
MONTREAL, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Canada’s COVID-19 Immunity Task Force (CITF) is supporting a BC Children’s Hospital-led research project that...
Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors
MENLO PARK, Calif. and BOSTON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering...
Rapid Therapeutic Completes $14 Million Acquisition of Razor Jacket
Razor Jacket is an Isolate Lab capable of producing up to 250 kilograms per month of 99.9% pure medical grade...
Agios Announces the Phase 3 ACTIVATE Trial of Mitapivat Achieved Its Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
– 40 Percent of Patients Treated with Mitapivat Achieved a Sustained Hemoglobin Increase of ≥1.5 g/dL Compared to 0 Placebo...
Praxis Precision Medicines Announces CFO Transition
CAMBRIDGE, Mass., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Maryville, TN
RAMSEY, N.J. and BOCA RATON, Fla. and MARYVILLE, Tenn., Dec. 01, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA)...